| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99215 |
Prolong outpt/office vis |
5,604 |
5,170 |
$222K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,528 |
5,105 |
$200K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
298 |
293 |
$16K |
| 20553 |
|
586 |
575 |
$11K |
| 76881 |
|
499 |
451 |
$9K |
| 20610 |
|
440 |
425 |
$8K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,512 |
1,450 |
$7K |
| M0220 |
Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring |
31 |
26 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,014 |
961 |
$4K |
| 99205 |
Prolong outpt/office vis |
202 |
202 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
850 |
811 |
$577.13 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
150 |
129 |
$571.65 |